Hikma Wants Extension At High Court In Skinny Label Case
By Adam Lidgett · January 2, 2025, 5:44 PM EST
Hikma Pharmaceuticals USA Inc. wants an extra month to file its petition challenging the Federal Circuit's revival of a suit claiming the company induced physicians to infringe patents covering Amarin Pharma...
To view the full article, register now.